サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1266493

製剤開発アウトソーシング世界市場：サービスタイプ別、製剤化ルート別、エンドユーザー別：機会分析と産業予測、2021-2031年

Formulation Development Outsourcing Market By Services Type, By Route of Formulation, By End-user : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日: | 発行: Allied Market Research | ページ情報: 英文 240 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
製剤開発アウトソーシング世界市場：サービスタイプ別、製剤化ルート別、エンドユーザー別：機会分析と産業予測、2021-2031年
出版日: 2023年02月01日
発行: Allied Market Research
ページ情報: 英文 240 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の製剤開発アウトソーシング市場は、2022年から2031年にかけてCAGR 9.0%で、2021年の31億5,680万米ドルから成長し、2031年には65億1,880万米ドルを獲得すると想定されています。

医薬品の特許性、寿命、成功を評価するプロセスは、製剤開発と呼ばれるものです。プレフォーミュレーション活動には、分析アッセイの開発と特性評価、製品の安定化や溶解度向上のための賦形剤スクリーニング、および剤形が含まれます。時間的な制約や社内のリソース不足のため、頻繁にアウトソーシングされます。製剤開発のアウトソーシングには、期間の短縮、知識へのアクセスの容易さ、不良品に対する保護の強化など、多くの利点もあります。

特にインドのような発展途上国では、あらゆるレベルの医薬品開発者が医薬品の製剤開発・製造のアウトソーシングに興味を持ち始めています。感染症や慢性疾患の大きな負担に起因する新規薬剤のニーズの高まりは、製剤開発の需要を促進する主な要因の一つです。また、バイオアベイラビリティを高めるために難水溶性の化学物質を作り出すことが重視されており、特許の有効期限も迫っています。伝染性ウイルスの治療法を特定するための臨床試験の必要性も、COVID-19の発生に影響されています。その結果、医薬品の研究開発に多額の資金が投入され、業界を活性化させることが予想されます。

研究開発費の増加により、製剤開発のアウトソーシングの需要が高まることが予想されます。リソースが不足している中小製薬企業では、製剤開発のアウトソーシングサービスを利用することが多いです。試験関連費用のため、製薬企業の大半が製剤開発のアウトソーシングサービスに費やす時間を短縮するために利用します。製薬業界が学術機関との連携に依存するようになったのは、製剤開発アウトソーシング業界の成長によるものです。

製剤開発アウトソーシング市場は、企業による医薬品開発のアウトソーシングに必要な予算が高額であることから、抑制されると予想されます。また、物質の複雑化により、製剤開発者の負担が増大しています。様々な医薬品や原材料の価格や需要の増加は、製剤開発アウトソーシングの市場価値に大きなマイナスの影響を与える可能性があります。さまざまな活性化学物質の配合、規制の強化、社会や顧客の嗜好の変化、環境への配慮などは、製品の誕生、使用、最終的な分解に影響を及ぼします。環境に与える影響だけでなく、処方者は自分たちの製品が消費者や患者にどのような利益をもたらすかにも関心を寄せています。

製薬会社やバイオ医薬品会社が業務をアウトソーシングするケースが増えたことで、製剤開発のアウトソーシング市場も拡大しています。COVID-19のパンデミックは、製剤医薬品アウトソーシング市場に好影響を与えると予想されます。ヘルスケア専門家、研究者、科学者の間で、ウイルス感染症を治療するための効果的な薬剤やワクチンの発見に対する高い需要が、研究開発活動を後押ししています。多くの製剤開発アウトソーシング会社が活発になり、大手企業や研究機関から医薬品開発の製剤プロジェクトを受注するようになりました。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • トップインパクトファクター
    • トップインベストメントポケット
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • COVID-19市場への影響度分析
  • 主要レギュレーション分析
  • 市場シェア分析
  • 特許の情勢
  • 規制ガイドライン
  • バリューチェーン分析

第4章 製剤開発アウトソーシング市場：サービスタイプ別

  • 概要
    • 市場規模・予測
  • プリフォーミュレーション
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • 製剤開発
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析

第5章 製剤開発アウトソーシング市場：製剤化ルート別

  • 概要
    • 市場規模・予測
  • オーラル
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • インジェクタブル
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • その他
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析

第6章 製剤開発アウトソーシング市場：エンドユーザー別

  • 概要
    • 市場規模・予測
  • 製薬業界
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • 調査機関・学術機関
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析

第7章 製剤開発アウトソーシング市場：地域別

  • 概要
    • 市場規模・予測：地域別
  • 北米
    • 主な動向と機会
    • 市場規模・予測：サービスタイプ別
    • 市場規模・予測：製剤化ルート別
    • 市場規模・予測：エンドユーザー別
    • 市場規模・予測：国別
      • 米国
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：サービスタイプ別
      • 市場規模・予測：製剤化ルート別
      • 市場規模・予測：エンドユーザー別
      • カナダ
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：サービスタイプ別
      • 市場規模・予測：製剤化ルート別
      • 市場規模・予測：エンドユーザー別
      • メキシコ
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：サービスタイプ別
      • 市場規模・予測：製剤化ルート別
      • 市場規模・予測：エンドユーザー別
  • 欧州
    • 主な動向と機会
    • 市場規模・予測：サービスタイプ別
    • 市場規模・予測：製剤化ルート別
    • 市場規模・予測：エンドユーザー別
    • 市場規模・予測：国別
      • ドイツ
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：サービスタイプ別
      • 市場規模・予測：製剤化ルート別
      • 市場規模・予測：エンドユーザー別
      • 英国
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：サービスタイプ別
      • 市場規模・予測：製剤化ルート別
      • 市場規模・予測：エンドユーザー別
      • フランス
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：サービスタイプ別
      • 市場規模・予測：製剤化ルート別
      • 市場規模・予測：エンドユーザー別
      • スペイン
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：サービスタイプ別
      • 市場規模・予測：製剤化ルート別
      • 市場規模・予測：エンドユーザー別
      • イタリア
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：サービスタイプ別
      • 市場規模・予測：製剤化ルート別
      • 市場規模・予測：エンドユーザー別
      • その他欧州
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：サービスタイプ別
      • 市場規模・予測：製剤化ルート別
      • 市場規模・予測：エンドユーザー別
  • アジア太平洋地域
    • 主な動向と機会
    • 市場規模・予測：サービスタイプ別
    • 市場規模・予測：製剤化ルート別
    • 市場規模・予測：エンドユーザー別
    • 市場規模・予測：国別
      • 中国
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：サービスタイプ別
      • 市場規模・予測：製剤化ルート別
      • 市場規模・予測：エンドユーザー別
      • 日本
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：サービスタイプ別
      • 市場規模・予測：製剤化ルート別
      • 市場規模・予測：エンドユーザー別
      • インド
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：サービスタイプ別
      • 市場規模・予測：製剤化ルート別
      • 市場規模・予測：エンドユーザー別
      • 韓国
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：サービスタイプ別
      • 市場規模・予測：製剤化ルート別
      • 市場規模・予測：エンドユーザー別
      • オーストラリア
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：サービスタイプ別
      • 市場規模・予測：製剤化ルート別
      • 市場規模・予測：エンドユーザー別
      • その他アジア太平洋地域
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：サービスタイプ別
      • 市場規模・予測：製剤化ルート別
      • 市場規模・予測：エンドユーザー別
  • LAMEA
    • 主な動向と機会
    • 市場規模・予測：サービスタイプ別
    • 市場規模・予測：製剤化ルート別
    • 市場規模・予測：エンドユーザー別
    • 市場規模・予測：国別
      • ブラジル
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：サービスタイプ別
      • 市場規模・予測：製剤化ルート別
      • 市場規模・予測：エンドユーザー別
      • サウジアラビア
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：サービスタイプ別
      • 市場規模・予測：製剤化ルート別
      • 市場規模・予測：エンドユーザー別
      • アラブ首長国連邦
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：サービスタイプ別
      • 市場規模・予測：製剤化ルート別
      • 市場規模・予測：エンドユーザー別
      • 南アフリカ
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：サービスタイプ別
      • 市場規模・予測：製剤化ルート別
      • 市場規模・予測：エンドユーザー別
      • LAMEAの残りの地域
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：サービスタイプ別
      • 市場規模・予測：製剤化ルート別
      • 市場規模・予測：エンドユーザー別

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • トップ企業のポジショニング、2021年

第9章 企業プロファイル

  • Charles River Laboratories International, Inc.
  • syngene international limited
  • Catalent Inc
  • Piramal Pharma Limited
  • Intertek Group Plc
  • Thermo Fisher Scientific Inc.
  • Eurofins Scientific
  • Laboratory Corporation of America Holdings
  • Dr Reddy's Laboratories Ltd.
  • Emergent BioSolutions, Inc.
図表

LIST OF TABLES

  • TABLE 01. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 02. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR PRE-FORMULATION, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 03. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR FORMULATION DEVELOPMENT, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 04. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 05. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR ORAL, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 06. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR INJECTABLE, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 07. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 08. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 09. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR PHARMACEUTICAL INDUSTRIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. U.S. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. U.S. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. U.S. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. UK FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. UK FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. UK FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. REST OF EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. REST OF EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. REST OF EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. REST OF ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. REST OF ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. REST OF LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. REST OF LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 87. REST OF LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 88. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: KEY EXECUTIVES
  • TABLE 89. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT
  • TABLE 90. SYNGENE INTERNATIONAL LIMITED: KEY EXECUTIVES
  • TABLE 91. SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT
  • TABLE 92. CATALENT INC: KEY EXECUTIVES
  • TABLE 93. CATALENT INC: COMPANY SNAPSHOT
  • TABLE 94. PIRAMAL PHARMA LIMITED: KEY EXECUTIVES
  • TABLE 95. PIRAMAL PHARMA LIMITED: COMPANY SNAPSHOT
  • TABLE 96.  INTERTEK GROUP PLC: KEY EXECUTIVES
  • TABLE 97.  INTERTEK GROUP PLC: COMPANY SNAPSHOT
  • TABLE 98. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
  • TABLE 99. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 100. EUROFINS SCIENTIFIC: KEY EXECUTIVES
  • TABLE 101. EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 102. LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY EXECUTIVES
  • TABLE 103. LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT
  • TABLE 104. DR REDDY'S LABORATORIES LTD.: KEY EXECUTIVES
  • TABLE 105. DR REDDY'S LABORATORIES LTD.: COMPANY SNAPSHOT
  • TABLE 106. EMERGENT BIOSOLUTIONS, INC.: KEY EXECUTIVES
  • TABLE 107. EMERGENT BIOSOLUTIONS, INC.: COMPANY SNAPSHOT

LIST OF FIGURES

  • FIGURE 01. FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN FORMULATION DEVELOPMENT OUTSOURCING MARKET (2022-2031)
  • FIGURE 04. PORTER FIVE-1
  • FIGURE 05. PORTER FIVE-2
  • FIGURE 06. PORTER FIVE-3
  • FIGURE 07. PORTER FIVE-4
  • FIGURE 08. PORTER FIVE-5
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALFORMULATION DEVELOPMENT OUTSOURCING MARKET
  • FIGURE 10. IMPACT OF KEY REGULATION: FORMULATION DEVELOPMENT OUTSOURCING MARKET
  • FIGURE 11. MARKET SHARE ANALYSIS: FORMULATION DEVELOPMENT OUTSOURCING MARKET
  • FIGURE 12. PATENT ANALYSIS BY COMPANY
  • FIGURE 13. PATENT ANALYSIS BY COUNTRY
  • FIGURE 14. REGULATORY GUIDELINES: FORMULATION DEVELOPMENT OUTSOURCING MARKET
  • FIGURE 15. VALUE CHAIN ANALYSIS: FORMULATION DEVELOPMENT OUTSOURCING MARKET
  • FIGURE 16. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR PRE-FORMULATION, BY COUNTRY 2021-2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR FORMULATION DEVELOPMENT, BY COUNTRY 2021-2031(%)
  • FIGURE 19. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR ORAL, BY COUNTRY 2021-2031(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR INJECTABLE, BY COUNTRY 2021-2031(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 23. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR PHARMACEUTICAL INDUSTRIES, BY COUNTRY 2021-2031(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY COUNTRY 2021-2031(%)
  • FIGURE 26. FORMULATION DEVELOPMENT OUTSOURCING MARKET BY REGION, 2021
  • FIGURE 27. U.S. FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. UK FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. REST OF EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. REST OF ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 42. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 43. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 44. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 45. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 46. REST OF LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 47. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 50. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 51. COMPETITIVE DASHBOARD
  • FIGURE 52. COMPETITIVE HEATMAP: FORMULATION DEVELOPMENT OUTSOURCING MARKET
  • FIGURE 53. TOP PLAYER POSITIONING, 2021
目次
Product Code: A31380

The global formulation development outsourcing market is envisioned to garner $6518.8 million by 2031, growing from $3156.8 million in 2021 at a CAGR of 9.0% from 2022 to 2031. The process of assessing the patentability, lifetime, and success of pharmaceutical products is referred to as formulation development. Pre-formulation activities include the development and characterization of analytical assays, excipient screening to stabilize or improve the product's solubility, and dosage form. Due to time constraints and a lack of internal resources, it is frequently outsourced. Outsourcing formulation development has a lot of advantages as well, including shortened timescales, easier access to knowledge, and increased protection against defective products.

Drug developers at all levels are becoming interested in outsourcing pharmaceutical formulation development and manufacture, particularly in developing nations like India. The rising need for novel medications as a result of the significant burden of infectious and chronic diseases is one of the main factors driving the demand for formulation development. In addition, there is a strong emphasis on creating poorly water-soluble chemicals to increase bioavailability and patent expirations. The necessity for clinical trials to identify a cure for contagious viruses has also been influenced by the COVID-19 outbreak. As a result, substantial funds have been spent on R&D to create medicines, which are predicted to boost the industry.

It is anticipated that higher R&D expenses will raise demand for outsourcing formulation development. Small and medium-sized pharmaceutical enterprises that lack the requisite resources frequently use outsourcing services for formulation development. Due to trial-related expenses, the majority of pharmaceutical businesses use it to shorten the time spent on outsourcing services for formulation development. The pharmaceutical industry's growing reliance on collaborations with academic institutions is caused by the growth of the formulation development outsourcing industry.

The formulation development outsourcing market is expected to be restrained owing to high amount of budget required for outsourcing drug development by the companies. Additionally, the complexity of the substances is growing for formulators. Increases in the price and demand for various medicines and raw materials have the potential to have a substantial negative impact on the market value of formulation development outsourcing. Incorporating various active chemicals, tightening restrictions, shifting societal and customer preferences, and environmental considerations all have an impact on the creation of a product, as do usage and eventual decomposition. In addition to their total environmental impact, formulators are concerned with how their products will benefit consumers and patients.

The number of pharmaceutical and biopharmaceutical businesses outsourcing their work has led to an expansion of the formulation development outsourcing market. The COVID-19 pandemic is expected to have a positive impact on the formulation drug outsourcing market. The high demand for effective drug or vaccine discovery among healthcare professionals, researchers and scientists to treat the viral infection has boosted the research and development activities. Many contract formulation development outsourcing companies became active and started taking drug development formulation projects from major companies and even research institutes.

The key players profiled in this report include: Charles River Laboratories, Syngene International Limited, Catalent, Inc, Piramal Pharma Ltd., Intertek Group plc, Thermo Fisher Scientific, Eurofins Scientific, Laboratory Corporation of America Holdings., Dr. Reddy's Laboratories Ltd., and EMERGENT.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the formulation development outsourcing market analysis from 2021 to 2031 to identify the prevailing formulation development outsourcing market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the formulation development outsourcing market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global formulation development outsourcing market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Services Type

  • Pre-Formulation
  • Formulation Development

By Route of Formulation

  • Oral
  • Injectable
  • Others

By End-user

  • Pharmaceutical Industries
  • Research and Academic Institutes

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • United Arab Emirates
    • South Africa
    • Rest of LAMEA

Key Market Players

  • Charles River Laboratories International, Inc.
  • syngene international limited
  • Catalent Inc
  • Piramal Pharma Limited
  •  Intertek Group Plc
  • Thermo Fisher Scientific Inc.
  • Eurofins Scientific
  • Laboratory Corporation of America Holdings
  • Dr Reddy's Laboratories Ltd.
  • Emergent BioSolutions, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
  • 3.5. COVID-19 Impact Analysis on the market
  • 3.6. Key Regulation Analysis
  • 3.7. Market Share Analysis
  • 3.8. Patent Landscape
  • 3.9. Regulatory Guidelines
  • 3.10. Value Chain Analysis

CHAPTER 4: FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Pre-Formulation
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Formulation Development
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Oral
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Injectable
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Pharmaceutical Industries
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Research and Academic Institutes
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country

CHAPTER 7: FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Services Type
    • 7.2.3. Market size and forecast, by Route of Formulation
    • 7.2.4. Market size and forecast, by End-user
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Services Type
      • 7.2.5.1.3. Market size and forecast, by Route of Formulation
      • 7.2.5.1.4. Market size and forecast, by End-user
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Services Type
      • 7.2.5.2.3. Market size and forecast, by Route of Formulation
      • 7.2.5.2.4. Market size and forecast, by End-user
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Services Type
      • 7.2.5.3.3. Market size and forecast, by Route of Formulation
      • 7.2.5.3.4. Market size and forecast, by End-user
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Services Type
    • 7.3.3. Market size and forecast, by Route of Formulation
    • 7.3.4. Market size and forecast, by End-user
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Services Type
      • 7.3.5.1.3. Market size and forecast, by Route of Formulation
      • 7.3.5.1.4. Market size and forecast, by End-user
      • 7.3.5.2. UK
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Services Type
      • 7.3.5.2.3. Market size and forecast, by Route of Formulation
      • 7.3.5.2.4. Market size and forecast, by End-user
      • 7.3.5.3. France
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Services Type
      • 7.3.5.3.3. Market size and forecast, by Route of Formulation
      • 7.3.5.3.4. Market size and forecast, by End-user
      • 7.3.5.4. Spain
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Services Type
      • 7.3.5.4.3. Market size and forecast, by Route of Formulation
      • 7.3.5.4.4. Market size and forecast, by End-user
      • 7.3.5.5. Italy
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Services Type
      • 7.3.5.5.3. Market size and forecast, by Route of Formulation
      • 7.3.5.5.4. Market size and forecast, by End-user
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Services Type
      • 7.3.5.6.3. Market size and forecast, by Route of Formulation
      • 7.3.5.6.4. Market size and forecast, by End-user
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Services Type
    • 7.4.3. Market size and forecast, by Route of Formulation
    • 7.4.4. Market size and forecast, by End-user
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. China
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Services Type
      • 7.4.5.1.3. Market size and forecast, by Route of Formulation
      • 7.4.5.1.4. Market size and forecast, by End-user
      • 7.4.5.2. Japan
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Services Type
      • 7.4.5.2.3. Market size and forecast, by Route of Formulation
      • 7.4.5.2.4. Market size and forecast, by End-user
      • 7.4.5.3. India
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Services Type
      • 7.4.5.3.3. Market size and forecast, by Route of Formulation
      • 7.4.5.3.4. Market size and forecast, by End-user
      • 7.4.5.4. South Korea
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Services Type
      • 7.4.5.4.3. Market size and forecast, by Route of Formulation
      • 7.4.5.4.4. Market size and forecast, by End-user
      • 7.4.5.5. Australia
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Services Type
      • 7.4.5.5.3. Market size and forecast, by Route of Formulation
      • 7.4.5.5.4. Market size and forecast, by End-user
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Key market trends, growth factors and opportunities
      • 7.4.5.6.2. Market size and forecast, by Services Type
      • 7.4.5.6.3. Market size and forecast, by Route of Formulation
      • 7.4.5.6.4. Market size and forecast, by End-user
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Services Type
    • 7.5.3. Market size and forecast, by Route of Formulation
    • 7.5.4. Market size and forecast, by End-user
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Services Type
      • 7.5.5.1.3. Market size and forecast, by Route of Formulation
      • 7.5.5.1.4. Market size and forecast, by End-user
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Services Type
      • 7.5.5.2.3. Market size and forecast, by Route of Formulation
      • 7.5.5.2.4. Market size and forecast, by End-user
      • 7.5.5.3. United Arab Emirates
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Services Type
      • 7.5.5.3.3. Market size and forecast, by Route of Formulation
      • 7.5.5.3.4. Market size and forecast, by End-user
      • 7.5.5.4. South Africa
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Services Type
      • 7.5.5.4.3. Market size and forecast, by Route of Formulation
      • 7.5.5.4.4. Market size and forecast, by End-user
      • 7.5.5.5. Rest of LAMEA
      • 7.5.5.5.1. Key market trends, growth factors and opportunities
      • 7.5.5.5.2. Market size and forecast, by Services Type
      • 7.5.5.5.3. Market size and forecast, by Route of Formulation
      • 7.5.5.5.4. Market size and forecast, by End-user

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

  • 9.1. Charles River Laboratories International, Inc.
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
  • 9.2. syngene international limited
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
  • 9.3. Catalent Inc
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
  • 9.4. Piramal Pharma Limited
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
  • 9.5.  Intertek Group Plc
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
  • 9.6. Thermo Fisher Scientific Inc.
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
  • 9.7. Eurofins Scientific
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
  • 9.8. Laboratory Corporation of America Holdings
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
  • 9.9. Dr Reddy's Laboratories Ltd.
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
  • 9.10. Emergent BioSolutions, Inc.
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot